BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 8:20 pm Sale | 2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 1,271,243 2.000% | -3,034,297 (-70.47%) | Filing |
| 2022-03-18 7:18 pm Sale | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 4,305,540 8.200% | -851,946 (-16.52%) | Filing |
| 2022-02-14 1:53 pm Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 5,157,486 9.990% | 1,658,140 (+47.38%) | Filing |
| 2021-02-12 6:52 pm Sale | 2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 3,499,346 10.000% | -17,505 (-0.50%) | Filing |
| 2020-06-22 5:17 pm Purchase | 2020-06-16 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 3,516,851 10.100% | 860,794 (+32.41%) | Filing |
| 2020-02-14 3:29 pm Purchase | 2019-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 2,656,057 9.990% | 53,221 (+2.04%) | Filing |